Related Experiment Video

Updated: Jul 8, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
07:17

Production and Detection of Reactive Oxygen Species (ROS) in Cancers

Published on: November 21, 2011

Reactive oxygen species: current knowledge and applications in cancer research and therapeutic

Andy T Y Lau1, Ying Wang, Jen-Fu Chiu

  • 1Department of Anatomy, The University of Hong Kong, Pokfulam, Hong Kong SAR, People's Republic of China.

Journal of Cellular Biochemistry
|January 4, 2008
PubMed

Insights

Reactive oxygen species (ROS) are vital cellular products with dual roles. While high ROS levels cause disease, controlled ROS generation shows promise as a novel cancer therapeutic strategy.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Oncology

Background:

  • Reactive oxygen species (ROS) are metabolic byproducts essential for cellular function.
  • Imbalances in ROS levels can lead to cellular damage, inducing apoptosis or promoting diseases like arteriosclerosis.
  • Cells possess antioxidant systems to maintain redox homeostasis, balancing ROS production and detoxification.

Purpose of the Study:

  • To review the paradoxical roles of ROS in cellular processes.
  • To explore the potential of ROS as chemotherapeutic agents in cancer treatment.
  • To discuss the current understanding of ROS in both disease pathogenesis and therapeutic applications.

Main Methods:

  • Literature review of existing research on ROS.
  • Analysis of studies investigating ROS in cellular metabolism and disease.
  • Examination of evidence supporting ROS-based cancer therapies.

Main Results:

  • ROS exhibit dual functions, acting as both damaging agents and therapeutic tools.
  • Elevated ROS levels can trigger programmed cell death (apoptosis) in cancer cells.
  • Targeted ROS generation is a basis for developing novel anti-cancer drugs.

Conclusions:

  • ROS play a complex role in health and disease, necessitating a nuanced understanding.
  • The therapeutic potential of ROS in oncology is significant, offering new avenues for cancer treatment.
  • Further research into ROS modulation could lead to innovative chemotherapeutic strategies.

More Related Videos

High Throughput Screening Assessment of Reactive Oxygen Species (ROS) Generation using Dihydroethidium (DHE) Fluorescence Dye05:16

High Throughput Screening Assessment of Reactive Oxygen Species (ROS) Generation using Dihydroethidium (DHE) Fluorescence Dye

Published on: January 19, 2024

Analysis of Oxidative Stress in Zebrafish Embryos11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...